Academic Editor

D. Gareth Evans


Prof. Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures on hereditary breast cancer and cancer syndromes. He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer in Calman breast units implemented through a training course (1998-2011).

He has published 672 peer reviewed research publications; 255 as first or senior author. He has published over 100 reviews and chapters and has had a book published by Oxford University Press on familial cancer. In the last 5 years he has raised over £35 million in grants for multicentre and local studies – approximately £31 million to Manchester. He is Chief Investigator on two (£1.59 & £1 million) NIHR program grant (2009-2014 and 2016-2020) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011). He has led a successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service.

Epidemiology Genetics Medical Genetics Oncology

Institution affiliations

Work details

Professor of Medical Genetics and Cancer Epidemiology

University of Manchester
Genetic Medicine

Consultant in Genetic Medicine

Genetic Medicine

PeerJ Contributions

Academic Editor on

February 23, 2017
, , , , , , , , , , , , , , , , , , , PubMed 28243543